Insiders who reported open-market trades in the last 12 months at the companies Scott T. Garrett files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Hing C. Wong - $220K in HCWB purchases and sales in the last 12 months
Rebecca Byam - $20K in HCWB purchases and sales in the last 12 months
Lee Flowers - $20K in HCWB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Scott T. Garrett is a corporate insider, tracked as Director of HCW Biologics Inc. (HCWB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Scott T. Garrett last file a Form 4?
The most recent primary Form 4 on record is dated 31 July 2026, one of 4 filings going back to 2025.
Has Scott T. Garrett been buying or selling stock?
Recorded transactions: 6 open-market purchases ($510K) and 0 open-market sales across all tracked filings.
Scott T. Garrett is Director of HCW Biologics Inc. (HCWB). 4 SEC Form 4 filings on record going back to 2025, most recently on 31 July 2026. Most recent open-market trade: bought $20K of HCWB on 31 July 2026. Lifetime open-market purchases: $510K.
Recent transactions
4
The latest 4 SEC Form 4 transactions reported by Scott T. Garrett.
InsiderAlpha's records for Scott T. Garrett go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $128K (4 of 6 buys carry a usable dollar value, totaling $510K). The largest single buy on record is $250K of HCWB in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
